ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
4 hedge funds and large institutions have $1.2M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
1
Calls
$630K
Puts
$18K
Net Calls
+$612K
Net Calls Change
+$199K
Top Buyers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$394K |
| 2 |
2
Jane Street
New York
|
$521K |
| 3 |
3
Morgan Stanley
New York
|
$28K |
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $521K | +$328K | +7,994 | +170% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $394K | +$384K | +9,376 | +3,973% |
|
|
CG
3
Cutler Group
San Francisco,
California
| $258K | +$258K | +6,300 | New |
|
|
4
Morgan Stanley
New York
| $28K | +$28K | +689 | New |
|
|
VF
5
Virtu Financial
New York
| – | -$1.08M | -16,532 | Closed |
|